Tyrosine kinase inhibitor SU11274 increased tumorigenicity and enriched for melanoma-initiating cells by bioenergetic modulation

Lucia Kučerová(Cancer Research Institute of the Slovak Academy of Sciences), Miroslava Matúšková(Cancer Research Institute of the Slovak Academy of Sciences)
BMC Cancer
May 12, 2016
10.1186/s12885-016-2341-y
Cited by 10

Related Papers

Cisplatin-induced mesenchymal stromal cells-mediated mechanism contributing to decreased antitumor effect in breast cancer cells
|Cell Communication and Signaling|2016|80
ALDH1A3 upregulation and spontaneous metastasis formation is associated with acquired chemoresistance in colorectal cancer cells
|BMC Cancer|2018|74
ALDH1A inhibition sensitizes colon cancer cells to chemotherapy
|BMC Cancer|2018|73
Mirvetuximab Soravtansine Induces Potent Cytotoxicity and Bystander Effect in Cisplatin-Resistant Germ Cell Tumor Cells
|Cells|2025|2
The impact of c-Met inhibition on molecular features and metastatic potential of melanoma cells
|Neoplasma|2024|1